4.7 Article

Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells

期刊

CANCER LETTERS
卷 357, 期 2, 页码 591-601

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2014.12.023

关键词

PLK1; BI2536; Non-small cell lung cancer; Mitosis; Spindle assembly checkpoint; Mitotic catastrophe

类别

资金

  1. National Research Foundation of Korea (NRF) - Korea government (MSIP) [2012R1A2A2A01011164, 2011-0030072]
  2. National Research Foundation of Korea [2012R1A2A2A01011164] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Polo-like kinase 1 (PLK1), a critical kinase that regulates multiple steps in mitosis, is overexpressed in diverse human cancers; thus many PLK1 inhibitors have been developed as potential cancer therapeutic agents. One of these compounds, the PLK1-specific inhibitor BI2536, has been investigated as a cytotoxic drug in several cancers, including lung cancer; however, the detailed mechanism by which BI2536 induces defects in cell proliferation of non-small cell lung cancer (NSCLC) has not yet been determined. We found that 812536 treatment resulted in mitotic arrest due to improper formation of the mitotic spindles and mitotic centrosomes. The unattached kinetochores in BI2536-treated NSCLC cells activated the spindle assembly checkpoint (SAC). The prolonged activation of the SAC led to a type of apoptotic cell death referred to as mitotic catastrophe. Finally, BI2536-treated NSCLC cells show a defect in cell proliferation. Overall, these data indicate that PLK1 inhibition via mitotic disruption represents a potential approach for the treatment of NSCLC. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

CHK2-FOXK axis promotes transcriptional control of autophagy programs

Yuping Chen, Jinhuan Wu, Guang Liang, Guohe Geng, Fei Zhao, Ping Yin, Somaira Nowsheen, Chengming Wu, Yunhui Li, Lei Li, Wootae Kim, Qin Zhou, Jinzhou Huang, Jiaqi Liu, Chao Zhang, Guijie Guo, Min Deng, Xinyi Tu, Xiumei Gao, Zhongmin Liu, Yihan Chen, Zhenkun Lou, Kuntian Luo, Jian Yuan

SCIENCE ADVANCES (2020)

Article Biochemistry & Molecular Biology

SIRT2 Affects Primary Cilia Formation by Regulating mTOR Signaling in Retinal Pigmented Epithelial Cells

Jeaho Lim, Juyoung Son, Jaewook Ryu, Ja-Eun Kim

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

The bromodomain containing protein BRD-9 orchestrates RAD51-RAD54 complex formation and regulates homologous recombination-mediated repair

Qin Zhou, Jinzhou Huang, Chao Zhang, Fei Zhao, Wootae Kim, Xinyi Tu, Yong Zhang, Somaira Nowsheen, Qian Zhu, Min Deng, Yuping Chen, Bo Qin, Kuntian Luo, Baohua Liu, Zhenkun Lou, Robert W. Mutter, Jian Yuan

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Tandem Deubiquitination and Acetylation of SPRTN Promotes DNA-Protein Crosslink Repair and Protects against Aging

Jinzhou Huang, Qin Zhou, Ming Gao, Somaira Nowsheen, Fei Zhao, Wootae Kim, Qian Zhu, Yusuke Kojima, Ping Yin, Yong Zhang, Guijie Guo, Xinyi Tu, Min Deng, Kuntian Luo, Bo Qin, Yuichi Machida, Zhenkun Lou

MOLECULAR CELL (2020)

Article Multidisciplinary Sciences

USP52 regulates DNA end resection and chemosensitivity through removing inhibitory ubiquitination from CtIP

Ming Gao, Guijie Guo, Jinzhou Huang, Jake A. Kloeber, Fei Zhao, Min Deng, Xinyi Tu, Wootae Kim, Qin Zhou, Chao Zhang, Ping Yin, Kuntian Luo, Zhenkun Lou

NATURE COMMUNICATIONS (2020)

Letter Hematology

Mixed-lineage leukemia protein modulates the loading of let-7a onto AGO1 by recruiting RAN

Shouhai Zhu, Zhihong Chen, Dan Jiang, Ruiheng Wang, Xiaoyan Cheng, Dan Li, Qiongyu Xv, Fei Zhao, Wootae Kim, Guijie Guo, Chunjun Zhao, Zhenkun Lou, Han Liu

HAEMATOLOGICA (2021)

Article Biochemistry & Molecular Biology

DOCK7 protects against replication stress by promoting RPA stability on chromatin

Ming Gao, Guijie Guo, Jinzhou Huang, Xiaonan Hou, Hyoungjun Ham, Wootae Kim, Fei Zhao, Xinyi Tu, Qin Zhou, Chao Zhang, Qian Zhu, Jiaqi Liu, Yuanliang Yan, Zhijie Xu, Ping Yin, Kuntian Luo, John Weroha, Min Deng, Daniel D. Billadeau, Zhenkun Lou

Summary: DOCK7 acts as a critical regulator for replication stress response by promoting RPA stability on chromatin. Additionally, overexpression of DOCK7 in ovarian cancer and depletion of DOCK7 in cancer cells sensitizes them to camptothecin, highlighting potential therapeutic targets for overcoming chemoresistance.

NUCLEIC ACIDS RESEARCH (2021)

Article Oncology

LRRK2 inhibition potentiates PARP inhibitor cytotoxicity through inhibiting homologous recombination-mediated DNA double strand break repair

Lifeng Chen, Jing Hou, Xiangyu Zeng, Qiang Guo, Min Deng, Jake A. Kloeber, Xinyi Tu, Fei Zhao, Zheming Wu, Jinzhou Huang, Kuntian Luo, Wootae Kim, Zhenkun Lou

Summary: PARP inhibitors induce HR deficiency and increase cancer cell sensitivity to treatment, while LRRK2 inhibitors can increase ovarian cancer cell sensitivity to Olaparib and are associated with HR.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Genetics & Heredity

USP13 regulates the replication stress response by deubiquitinating TopBP1

Wootae Kim, Fei Zhao, Huanyao Gao, Sisi Qin, Jing Hou, Min Deng, Jake A. Kloeber, Jinzhou Huang, Qin Zhou, Guijie Guo, Ming Gao, Xiangyu Zeng, Shouhai Zhu, Xinyi Tu, Zheming Wu, Yong Zhang, Ping Yin, Scott H. Kaufmann, Kuntian Luo, Zhenkun Lou

Summary: This study identifies the deubiquitinating enzyme USP13 as a key regulator of TopBP1, stabilizing it and coordinating the replication stress response. High expression of USP13 enhances cancer cell chemoresistance and correlates with poor prognosis in cancer patients.

DNA REPAIR (2021)

Article Biotechnology & Applied Microbiology

ZNF423 modulates the AMP-activated protein kinase pathway and metformin response in a single nucleotide polymorphisms, estrogen and selective estrogen receptor modulator dependent fashion

Sisi Qin, James N. Ingle, Wootae Kim, Huanyao Gao, Richard M. Weinshilboum, Liewei Wang

Summary: The study identified potential pathways, including ribosome and AMP-activated protein kinase (AMPK) signaling, regulated by ZNF423 or ZNF423 rs9940645 SNP. The findings suggest that AMPK signaling is modulated by the ZNF423 rs9940645 SNP and may affect metformin response in breast cancer, potentially serving as a biomarker for personalized metformin treatment.

PHARMACOGENETICS AND GENOMICS (2021)

Article Multidisciplinary Sciences

Reciprocal regulation of RIG-I and XRCC4 connects DNA repair with RIG-I immune signaling

Guijie Guo, Ming Gao, Xiaochen Gao, Bibo Zhu, Jinzhou Huang, Xinyi Tu, Wootae Kim, Fei Zhao, Qin Zhou, Shouhai Zhu, Zheming Wu, Yuanliang Yan, Yong Zhang, Xiangyu Zeng, Qian Zhu, Ping Yin, Kuntian Luo, Jie Sun, Min Deng, Zhenkun Lou

Summary: The study reveals that RIG-I is recruited to double-stranded breaks, suppressing non-homologous end joining and compromising DNA repair, while XRCC4 plays a crucial role in RIG-I immune signaling. This reciprocal regulation uncovers a new function of RIG-I in suppressing virus integration and DNA repair, while endowing XRCC4 with a pivotal role in enhancing innate immune response.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

ASTE1 promotes shieldin-complex-mediated DNA repair by attenuating end resection

Fei Zhao, Wootae Kim, Huanyao Gao, Chao Liu, Yong Zhang, Yuping Chen, Min Deng, Qin Zhou, Jinzhou Huang, Qi Hu, Shih-Hsun Chen, Somaira Nowsheen, Jake A. Kloeber, Bo Qin, Ping Yin, Xinyi Tu, Guijie Guo, Sisi Qin, Chao Zhang, Ming Gao, Kuntian Luo, Yilun Liu, Zhenkun Lou, Jian Yuan

Summary: ASTE1, as a downstream effector of the shieldin complex, cleaves single-stranded and 3' overhang DNA to promote shieldin-dependent non-homologous end-joining, leading to impaired DSB repair and resistance to PARP inhibitors in BRCA1-deficient cells.

NATURE CELL BIOLOGY (2021)

Article Oncology

MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STING

Yong Zhang, Qifan Yang, Xiangyu Zeng, Manxiang Wang, Shuang Dong, Bin Yang, Xinyi Tu, Ting Wei, Wenzhuan Xie, Chao Zhang, Qiang Guo, Jake A. Kloeber, Yueyu Cao, Guijie Guo, Qin Zhou, Fei Zhao, Jinzhou Huang, Li Liu, Kai Zhang, Mingwei Wang, Ping Yin, Kuntian Luo, Min Deng, Wootae Kim, Jing Hou, Yu Shi, Qian Zhu, Lifeng Chen, Sheng Hu, Junqiu Yue, Guoliang Pi, Zhenkun Lou

Summary: The study found that tumors with MET amplification are resistant to immune checkpoint blockade (ICB) therapy, likely due to reduced levels of STING and antitumor T-cell infiltration. It also revealed that the oncogenic MET signaling pathway downregulates tumor cell STING expression through phosphorylation of UPF1 and modulation of the 3'-UTR length of STING. The efficiency of ICB in MET amplification can be improved by inhibiting MET, suggesting a potential combination therapy for patients with this condition.

CANCER DISCOVERY (2021)

Review Biochemistry & Molecular Biology

DNA Damage and Its Role in Cancer Therapeutics

Jaeyoung Moon, Ichiwa Kitty, Kusuma Renata, Sisi Qin, Fei Zhao, Wootae Kim

Summary: DNA damage has both positive and negative effects on cancer cells. It exacerbates gene mutation frequency and cancer risk, but it also makes cancer cells more sensitive to chemotherapy or radiotherapy. Inhibitors targeting key enzymes in the DNA repair pathway can induce synthetic lethality with cancer therapeutics. This study reviews the general pathways involved in DNA repair and potential protein targets for cancer therapeutics.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Maintaining Genome Integrity: Protein Kinases and Phosphatases Orchestrate the Balancing Act of DNA Double-Strand Breaks Repair in Cancer

Sisi Qin, Ichiwa Kitty, Yalan Hao, Fei Zhao, Wootae Kim

Summary: DNA double-strand breaks (DSBs) are the most lethal DNA damages that result in severe genome instability. Phosphorylation, which is one of the most important protein post-translation modifications, plays a vital role in regulating DSB repair. Kinases and phosphatases coordinate in DSB repair by adding or removing phosphate groups from various proteins. Understanding the function of kinases and phosphatases in DSBs repair is crucial for comprehending their role in cancer development and therapeutics.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Oncology

Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy

Xinru Zhou, Yin Jia, Chuanbin Mao, Shanrong Liu

Summary: Small extracellular vesicles (sEVs), such as exosomes, have emerged as crucial targets for liquid biopsy and promising drug delivery vehicles in tumor progression. They can serve as biomarkers for tumor diagnosis and as drug carriers for cancer treatment.

CANCER LETTERS (2024)

Article Oncology

HMGB1 in the interplay between autophagy and apoptosis in cancer

Ruochan Chen, Ju Zhu, Xiao Zhong, Jie Li, Rui Kang, Daolin Tang

Summary: The interplay between autophagy and apoptosis plays a crucial role in tumorigenesis and cancer therapy, with HMGB1 serving as a key regulator in these processes.

CANCER LETTERS (2024)

Article Oncology

Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer

Zongfu Pan, Xixuan Lu, Tong Xu, Jinming Chen, Lisha Bao, Ying Li, Yingying Gong, Yulu Che, Xiaozhou Zou, Zhuo Tan, Ping Huang, Minghua Ge

Summary: This study uncovered the emerging role of HN1 in promoting dedifferentiation of anaplastic thyroid cancer (ATC) cells. HN1 negatively regulated the thyroid differentiation markers and had an inhibitory effect on the transcriptional activation of CTCF, thereby influencing the chromatin accessibility of thyroid differentiation genes.

CANCER LETTERS (2024)

Article Oncology

Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis

Yi Qin, Shengjun Xiong, Jun Ren, Gautam Sethi

Summary: Autophagy plays an important regulatory role in glioblastoma, and its dysregulation can lead to drug resistance and radioresistance. It also affects stem cell characteristics, overall growth, and metastasis. Therefore, autophagy is a promising target for glioblastoma therapy.

CANCER LETTERS (2024)

Article Oncology

Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase

Katsuya Nagaoka, Xuewei Bai, Dan Liu, Kevin Cao, Joud Mulla, Chengcheng Ji, Hongze Chen, Muhammad Azhar Nisar, Amalia Bay, William Mueller, Grace Hildebrand, Jin-Song Gao, Shaolei Lu, Hiroko Setoyama, Yasuhito Tanaka, Jack R. Wands, Chiung-Kuei Huang

Summary: This study found that serum 2-OG levels in cholangiocarcinoma patients are associated with the effectiveness of chemotherapy. Patients with progressive disease showed significantly higher levels of serum 2-OG compared to stable disease and partial response patients. The study also revealed that overexpression of ASPH mimics the effects of 2-OG, and knockdown of ASPH improves chemotherapy. Targeting ASPH enhances the effects of chemotherapy by modulating ATM and ATR, two key regulators of DDRs.

CANCER LETTERS (2024)